The Pharma Data

SEPTEMBER 15, 2020

Find out solutions to mitigate the impact from clinical supply chain risk and discover how to improve dynamic drug supply forecasting strategies. Join this webinar to learn how supply forecasting and interactive response technology can help biotech companies improve supply planning and distribution while reducing cost and risk.

Clinical Supply 52

Clinical Supply Clinical Trials Doctors Clinical Development 52

Drug Target Review

SEPTEMBER 10, 2024

Drug developer companies across the pharma industry report notable reductions in drug development timelines where 10 to 12 months, from lead monoclonal antibody (mAb) identification to IND application, is the new norm and in which earlier Tox material generation has been a critical component for shortening IND timelines.

Drug Development 64

Drug Development Clinical Supply Production Protein Expression 64

The Pharma Data

AUGUST 15, 2021

VTX-801 is a novel investigational gene therapy to be evaluated in a Phase 1/2 clinical trial to determine the safety, tolerability, and pharmacological activity of a single intravenous infusion in adult patients with Wilson Disease. Pfizer is collaborating with Vivet on the clinical supply of VTX-801 for the Phase 1/2 clinical trial.

Disease 52

Disease FDA Treatment Clinical Trials 52

The Pharma Data

OCTOBER 27, 2020

Under the agreement, during the option period, Molecular Partners will conduct Phase 1 clinical trials for MP0420, expected to begin in November 2020, and perform all remaining preclinical work for MP0423 and Novartis will conduct Phase 2 and Phase 3 clinical trials, with Molecular Partners as sponsor of these trials. About Novartis.

Therapies 40

Therapies Virus Treatment Clinical Trials 40

BioPharma Drive: Drug Pricing

JUNE 9, 2025

Library resources Playbook First-Void Urine Testing: A Simpler Option for Screenings Custom content for DNA Genotek Virtual Event Playback State of Oncology Research Podcast Mastering Clinical Supply: How Clinical Supply Managers Turn Challenges into Solutions Custom content for Almac Clinical Services View all Company Announcements View all | Post (..)

Clinical Trials 144

Clinical Trials Drugs Therapies Clinical Supply 144

BioPharma Drive: Drug Pricing

JUNE 5, 2025

And for AI life sciences companies, Elsa’s debut may be a source of validation. The timeline is aggressive, especially given that the scope and rigor of the initial pilot testing wasnt fully showcased, but this reflects the urgency FDA feels about modernizing their review processes and doing more with less staff,” Sharma said.

FDA 130

FDA Therapies Clinical Supply Licensing 130

BioPharma Drive: Drug Pricing

JUNE 9, 2025

Most Popular Biotech funding plummets as Trump policies unnerve investors: Jefferies Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO FDA to use new review tool on Sarepta’s gene therapy work FDA meeting gives window into gene therapy field’s angst Library resources Playbook First-Void Urine Testing: A Simpler Option (..)

Trials 130

Trials Clinical Supply Clinical Trials Therapies 130